A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1993
11/25/1993	WO1993023393A1 Indazol-3-one-2-yl derivatives of benzopyrans
11/25/1993	WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993	WO1993023383A1 Gaba and l-glutamic acid analogs for antiseizure treatment
11/25/1993	WO1993023378A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
11/25/1993	WO1993023067A1 Igf-1 analogs
11/25/1993	WO1993023052A1 Use of guanylate cyclase inhibitors in the treatment of shock
11/25/1993	WO1993023024A1 Diamines in the treatment of arrhythmia
11/25/1993	WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993	DE4216942A1 Tetrahydro- und Perhydroisochinolin-Derivate und diese enthaltende therapeutische Mittel Tetrahydro- and perhydroisoquinoline derivatives and therapeutic agents containing them
11/25/1993	DE4216829A1 Pyridyl derivs. with antithrombotic properties
11/25/1993	DE4216364A1 Pyridyl derivs. with antithrombotic properties
11/25/1993	CA2135612A1 Diamines in the treatment of arrhythmia
11/25/1993	CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993	CA2135306A1 Igf-1 analogs
11/25/1993	CA2135211A1 Indazol-3-one-2-yl derivatives of benzopyrans
11/25/1993	CA2135188A1 6-amino substituted imidazo(4,5-b)pyridines as angiotensin ii antagonists
11/25/1993	CA2134765A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
11/25/1993	CA2113547A1 Purine derivatives
11/25/1993	CA2113546A1 Novel adenosine derivatives
11/24/1993	EP0571264A1 Autoadhesive matrix system for the transdermal controlled release of piribedil
11/24/1993	EP0570724A1 Salts of 3-(cis-2,6-dimethylpiperidino)-sydnonimine
11/24/1993	EP0570507A1 Anti-aggregatory peptides containing an aromatic ester or amide
11/24/1993	CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/23/1993	US5264578 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/23/1993	US5264454 Certain 2-oxo-tetrahydro-cycloalkyl-benzopyran-3yl ureas having acyl-CoA-cholesterol acyl transferase inhibitory activity
11/23/1993	US5264441 Anticholesterol agents
11/23/1993	US5264438 Dopamine receptor agonists
11/23/1993	US5264424 Modified gangliosides and the functional derivatives thereof
11/20/1993	CA2096511A1 Selfadhesive matricial system for the transdermal sustained liberation of piribedil
11/18/1993	EP0570263A1 New alkene carboxylic acid derivatives, process for their preparation and pharmaceutic compositions containing them
11/18/1993	EP0570245A2 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
11/18/1993	EP0569795A1 Sulphonylbenzyl substituted benzo- and pyridopyridones
11/18/1993	EP0569794A1 Biphenylmethyl-substituted pyridones useful as angiotensin II receptor antagonists.
11/18/1993	EP0569564A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
11/18/1993	EP0569493A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
11/18/1993	EP0569487A1 Endothelin converting enzyme inhibitors
11/17/1993	CN1078476A Partially modified and retro-inverted tetrapeptides analogues of C-reactive protein fragments
11/17/1993	CN1078471A Pharmaceuticals
11/17/1993	CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo \|2,3-c¨ pyridin-7-one derivatives
11/17/1993	CN1078468A Sulphonylbenzyl-substituted pyridones
11/17/1993	CN1078466A Benzoxazinone and benzothiazinone derivatives endowed with cardiovscular activity
11/17/1993	CN1022754C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method
11/17/1993	CA2096327A1 Salts of 3-(cis-2,6-dimethylpiperidino)sydnone imine
11/16/1993	US5262439 Soluble analogs of probucol
11/16/1993	US5262429 Aryl-quinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid compounds which have useful pharmaceutical utility
11/16/1993	US5262415 Aminopyridine compounds
11/16/1993	US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
11/16/1993	CA2096281A1 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
11/16/1993	CA1324383C Process for the manufacture of novel substituted aminomethanediphosphonic acids
11/16/1993	CA1324380C Pyridazinone derivatives
11/15/1993	CA2095404A1 Purification and characterization of a csvtcg-specific tumor cell adhesion receptor
11/14/1993	CA2096067A1 Diazabicycloalkene derivatives
11/13/1993	CA2095802A1 Biphenylmethyl-substituted pyridones
11/13/1993	CA2095801A1 Sulfonylbenzyl-substituted benzo- and pyridopyridones
11/11/1993	WO1993022449A1 Inhibitory factor
11/11/1993	WO1993022328A1 Adenosine derivatives having a2 agonist activity
11/11/1993	WO1993022302A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists
11/11/1993	WO1993022279A1 Diamine derivatives having selective affinity for sigma receptors
11/11/1993	WO1993022271A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
11/11/1993	WO1993021956A1 Antibodies to p-selectin and their uses
11/11/1993	WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993	WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993	WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993	WO1993021921A1 Anti-ischemic medicament
11/11/1993	WO1993021914A1 Soluble analogs of probucol
11/11/1993	CA2134658A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
11/11/1993	CA2134443A1 Inhibitory factor
11/11/1993	CA2134067A1 Adenosine derivatives having a2 agonist activity
11/11/1993	CA2133984A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists
11/11/1993	CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993	CA2112490A1 Diamine derivatives having selective affinity for sigma receptors
11/10/1993	EP0569193A1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists
11/10/1993	EP0569046A1 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
11/10/1993	EP0568545A1 Method of reducing elevated blood sugar levels in humans
11/09/1993	US5260440 Pyrimidine derivatives
11/09/1993	US5260336 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
11/09/1993	US5260330 Substituted anilides
11/09/1993	US5260318 Phenylpiperidylamines and drugs containing them
11/09/1993	CA1324140C 2-phenyl-3-acylaminomethyl-5,6,7,8-tetrahydroimidazo [1,2-a]pyridine derivatives
11/09/1993	CA1324139C 2-phenyl-3-acylaminomethyl-imidazo[1,2-a]pyridine derivatives
11/09/1993	CA1324129C Prostaglandins of the f series
11/07/1993	CA2095174A1 Phenyl sulfonamide endothelin antagonists
11/03/1993	EP0568310A1 Composition comprising heparin and rapamycin
11/03/1993	EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates
11/03/1993	EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors
11/03/1993	EP0567997A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical
11/03/1993	EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993	EP0357788B1 Pyridazinone derivatives
11/03/1993	CN1077955A Heterocyclic derivatives
11/03/1993	CN1077954A 新的苯并吡喃衍生物 New benzopyran derivatives
11/03/1993	CN1077953A 乙酸衍生物 Acetic acid derivatives
11/02/1993	CA2094332A1 Urokinase inhibitors
10/1993
10/31/1993	CA2095206A1 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine n-oxides, processes for their preparation, and their use as medicaments
10/28/1993	WO1993021302A1 Cadherin materials and methods
10/28/1993	WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993	WO1993021219A1 Endothelin antagonists ii
10/28/1993	WO1993021214A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
10/28/1993	WO1993021213A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
10/28/1993	WO1993021212A1 Lactam dipeptides having hle inhibiting activity
10/28/1993	WO1993021210A1 Pyrimidinyl acetamides as elastase inhibitors

1 ... 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 ... 1595